This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignee: Astrazeneca Ab. Active years: 2023-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2026
Title: Virendar Kaushik: Innovator in PCSK9 Inhibitors
Introduction
Virendar Kaushik is a notable inventor based in Bedford, MA (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of PCSK9 inhibitors. His work focuses on innovative methods that target the PCSK9 protein, which plays a crucial role in cholesterol regulation.
Latest Patents
Virendar holds 1 patent for his invention titled "PCSK9 inhibitors and methods of use thereof." This patent describes a novel inhibitor pharmacophore of PCSK9 and heteroaryl compounds that effectively bind to the PCSK9 protein. This innovation has the potential to impact the treatment of hypercholesterolemia and related cardiovascular diseases.
Career Highlights
Virendar is currently employed at AstraZeneca AB, a leading global biopharmaceutical company. His role involves research and development in the area of cardiovascular therapies. His expertise and innovative approach have positioned him as a valuable asset in the pharmaceutical industry.
Collaborations
Some of his notable coworkers include Michael H Serrano-Wu and Brian K Hubbard. Their collaborative efforts contribute to the advancement of research in the field of PCSK9 inhibitors and other therapeutic areas.
Conclusion
Virendar Kaushik's work in developing PCSK9 inhibitors showcases his commitment to advancing medical science. His contributions are paving the way for new treatments that could significantly improve patient outcomes in cardiovascular health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile